Ronald Duman
Elizabeth Mears and House Jameson Professor of Psychiatry and Professor of Neuroscience at Yale School of Medicine
Data updated
Research Footprint
Ronald Duman appears in 7 tracked papers (2014–2020), most studied alongside Ketamine and Placebo, across Depressive Disorders, Major Depressive Disorder (MDD) and PTSD.
Most-cited paper: Ketamine: A Paradigm Shift for Depression Research and Treatment (437 citations).
Frequent co-authors: Gerard Sanacora, John Krystal and Chadi Abdallah.
Background & Research
Ronald S. Duman was a Yale neuroscientist and psychiatrist whose research focused on the molecular and cellular basis of stress, depression, and antidepressant response. He was a pioneer in identifying signaling pathways underlying ketamine’s rapid-acting antidepressant effects and held senior professorships at Yale School of Medicine. He died in 2020, but his work remains foundational in psychiatric and psychedelic-related research.
Key Impact
A leading neuroscientist whose work helped establish the rapid antidepressant mechanism of ketamine and shaped modern neurobiology of depression and PTSD.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Ronald Duman is associated with.